Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Verhelst

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Biochemical Pharmacology|July 6, 2010
Expression, biological activities and mechanisms of action of A20 (TNFAIP3)Lynn Verstrepen, Kelly Verhelst, Geert van Loo, et al.
The EMBO Journal|October 4, 2012
A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7Kelly Verhelst, Isabelle Carpentier, Marja Kreike, et al.
The Journal of Biological Chemistry|November 8, 2006
LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activationAndy Wullaert, Lynn Verstrepen, Sofie Van Huffel, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Biochemical Pharmacology|July 6, 2010
Expression, biological activities and mechanisms of action of A20 (TNFAIP3)Lynn Verstrepen, Kelly Verhelst, Geert van Loo, et al.
The EMBO Journal|October 4, 2012
A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7Kelly Verhelst, Isabelle Carpentier, Marja Kreike, et al.
The Journal of Biological Chemistry|November 8, 2006
LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-kappaB activationAndy Wullaert, Lynn Verstrepen, Sofie Van Huffel, et al.
Pageof 2